About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3639605
Allelic
Composition
Faslpr/Faslpr
Genetic
Background
MRL/MpJ-Faslpr/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (82 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 50% mortality is observed at 5 months with 90% mortality at 7.5 months, significantly reduced from wild-type

cellular
• mild increase in mesangial cells is seen at 20 weeks of age

immune system
• larger lymph nodes often show extensive hemorrhage
• CD19+IgM+ immature B cells are reduced in the spleen
• numbers of the T1 subset of B cells is reduced
• mild to moderated neutrophil accumulation is observed at 20 weeks
• CD19+ IgDhigh IgMlow B cells are severely reduced in the spleen
• numbers of marginal zone (MZ) B cells is reduced
• increased B220+IgM+ cells are observed in bone marrow; number of IgG-secreting cells are significantly increased compared to Faslpr homozygotes
• staining intensity and number of germinal centers (GCs) is reduced 10 days post-challenge with NP-KLH antigen, compared to controls
• in vitro, splenic B cells produce significantly higher amounts of IgG1 in response to LPS and anti-CD40 plus Il4 stimulation, and higher amounts of IgG2a upon LPS stimulation
• production of anti-NP IgG is impaired in spleen cells
• IgG and IgM levels are increased in serum at 6 months (J:7454)
• mice display hypergammaglobulinemia; serum levels are comparable to Fas homozygotes (J:122315)
• mice exhibit increased serum IgG levels and IgG deposits in the kidney unlike wild-type mice
• nodes are 62 times normal size (J:7454)
• larger lymph nodes often show extensive necrosis
• mice exhibit increased serum levels of kappa-chain rheumatoid factor and DNA auto-antibodies, lymphadenopathy, glomerulonephritis, renal immunoglobulin deposits, proteinuria, and end organ disease compared to in wild-type mice
• at 16 weeks, levels of anti-cardiolipin antibodies are significantly higher than in wild-type controls; levels are significantly higher at 8 weeks (J:14151)
• mice exhibit increased serum levels of kappa-chain rheumatoid factor compared to in wild-type mice (J:92084)
• mice have significantly increased levels of anti-ssDNA antibodies (J:7454)
• at 16 weeks, anti-DNA titers are significantly higher than in wild-type controls (J:14151)
• DNA auto-antibodies are increased compared to in wild-type mice at 12 weeks (J:92084)
• by 5-6 months of age, Fas-deficient mice have antinuclear antibody (ANA) levels comparable to >50% of C4b-deficient females (on Ighb haplotype homozygous background) (J:111811)
• antibodies are increased relative to controls and other mutant strains with Faslpr mutations (J:7454)
• mice produce high titers of IgG1 and IgG2a anti-dsDNA antibodies, comparable to Fas homozygotes (J:122315)
• at 20 weeks, all mice show mononuclear infiltrates in the choroid plexus; at 10 weeks, all mice display monuclear infiltrates
• Background Sensitivity: severe immune complex glomerulonephritis develops by 6 months (J:7454)
• mice show deposition of IgG or C3 in kidneys and inflammation, similar to Fas homozygotes (J:122315)
• kidney lesions have lower scores than those in double mutants at 20 weeks (J:127199)

muscle
• myocardium neighboring the heart valves shows mononuclear infiltration of the vessels, but valves are normal

hematopoietic system
• CD19+IgM+ immature B cells are reduced in the spleen
• numbers of the T1 subset of B cells is reduced
• mild to moderated neutrophil accumulation is observed at 20 weeks
• CD19+ IgDhigh IgMlow B cells are severely reduced in the spleen
• numbers of marginal zone (MZ) B cells is reduced
• increased B220+IgM+ cells are observed in bone marrow; number of IgG-secreting cells are significantly increased compared to Faslpr homozygotes
• staining intensity and number of germinal centers (GCs) is reduced 10 days post-challenge with NP-KLH antigen, compared to controls
• in vitro, splenic B cells produce significantly higher amounts of IgG1 in response to LPS and anti-CD40 plus Il4 stimulation, and higher amounts of IgG2a upon LPS stimulation
• production of anti-NP IgG is impaired in spleen cells
• IgG and IgM levels are increased in serum at 6 months (J:7454)
• mice display hypergammaglobulinemia; serum levels are comparable to Fas homozygotes (J:122315)
• mice exhibit increased serum IgG levels and IgG deposits in the kidney unlike wild-type mice

renal/urinary system
• mice have excessive urinary albumin compared to wild-type (>10-fold) at 3-4 months
• foot processes are only focally effaced
• dilated capsules are observed in mice at 3-4 months
• abnormalities due to severe glomerulonephritis (J:7454)
• at 20 weeks, lesions show some neutrophil infiltration and hypercellularity (J:127199)
• tuft necrosis, capsular proliferation and fibrosis are less common and less severe than observed in double mutants (J:127199)
• mild increase in mesangial cells is seen at 20 weeks of age
• mild increase in mesangial matrix is seen at 20 weeks of age
• glomerulonephritic changes such as hypercellularity, lobularity, dilated capsules and crescent formation or enlarged glomeruli are observed in mice at 3-4 months
• Background Sensitivity: severe immune complex glomerulonephritis develops by 6 months (J:7454)
• mice show deposition of IgG or C3 in kidneys and inflammation, similar to Fas homozygotes (J:122315)
• kidney lesions have lower scores than those in double mutants at 20 weeks (J:127199)
• crescent formation is observed in mice at 3-4 months
• enlarged glomeruli are observed in mice at 3-4 months
• progressive decline in renal function is observed, during progression to end-stage renal disease

behavior/neurological
• mice show increased latency to locate hidden platform in water maze testing on days 2-5 of testing at 8 weeks of age; at 16 weeks in spatial bias testing, mutants spend less time and travel reduced distances in quadrant of platform's previous location compared to controls
• equilibrium is significantly impaired in mice at 18-20 weeks, as measured by performance in rotarod tests

vision/eye

cardiovascular system
• myocardium neighboring the heart valves shows mononuclear infiltration of the vessels, but valves are normal
• larger lymph nodes often show extensive hemorrhage

hearing/vestibular/ear
• slight degenerative changes in the stria vascularis of both the apical and basal turns
• the basement membrane of the capillaries in the stria vascularis was thickened
• widened intercellular space in the stria vascularis
• the basal infolding of strial marginal cells
• thinned intermediate cell layer
• the ABR threshold f the 20-week-old mutant mice were significantly higher than those of the 4-week-old mutant mice and the 20-week-old wild-type BALB/c mice

nervous system
• at 20 weeks, all mice show mononuclear infiltrates in the choroid plexus; at 10 weeks, all mice display monuclear infiltrates

homeostasis/metabolism
• mice have excessive urinary albumin compared to wild-type (>10-fold) at 3-4 months
• Background Sensitivity: 7-8 week old mice show 2-3 fold induction of Dnase1l3 in macrophages and 4-5 fold induction in splenocytes over C57BL/6; levels in other strains like BXSB/MpJ and (NZB x NZW)F1 are similarly elevated compared to B6
• Background Sensitivity: mice show a dramatic defect (~8-fold decrease) in macrophage-secreted Dnase1l3 barrier to liposomal (BT) activity compared to B6; (NZB x NZW)F1 mice show a similar defect in BT activity

pigmentation
• thinned intermediate cell layer

digestive/alimentary system

endocrine/exocrine glands

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Sjogren's syndrome DOID:12894 OMIM:270150
J:123192


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory